- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00354614
Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)
April 11, 2017 updated by: ResMed
Validation of the ApneaLink Sleep Screener in a Suspected Sleep Disordered Breathing Population
The primary endpoints for this study are that the AL validation will 1) achieve a sensitivity of greater than 80% for AHI values greater than or equal to 15, and 2) demonstrate a correlation coefficient of r=0.75 indicating strong correlation between the AHI of diagnostic PSG and AL.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All subjects with suspected Sleep Disordered Breathing (SDB) scheduled for diagnostic polysomnography (PSG) will be invited to participate in the study to be tested to determine if they have Sleep Disordered Breathing (SDB), using the ApneaLink (AL) Sleep Screener.
Subjects initially will be tested for SDB in the home environment.
Following an AL home test, subjects will undergo a simultaneous, attended diagnostic polysomnography (PSG) sleep study and ApneaLink test for the purpose of confirming and comparing the results between diagnostic PSG and the AL device.
Study Type
Observational
Enrollment (Actual)
81
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Pts. with suspected OSA.
Description
Inclusion Criteria:
- Adult subjects ( greater than 18 years of age) of either gender or any race
- Suspected sleep disordered breathing
- Untreated sleep disordered breathing
- Willingness to use AL at home within 2 days of receipt and instruction on the AL
- Willingness to use AL at home and undergo PSG within 2 to 4 weeks of completing the at home AL test
Exclusion Criteria:
- Any subject requiring home oxygen therapy
- Any subject currently receiving positive airway pressure therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensitivity and Specificity
Time Frame: Simultaneous single night recording
|
Comparison of sensitivity and specificity of ApneaLink to polysomnography with an apnea hypopnea index (AHI) cut-off of 15 or greater
|
Simultaneous single night recording
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Patrick J Strollo, MD, Associate Professor of medicine and Medical Director, UPMC Sleep Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2006
Primary Completion (Actual)
March 1, 2007
Study Completion (Actual)
July 1, 2007
Study Registration Dates
First Submitted
July 18, 2006
First Submitted That Met QC Criteria
July 18, 2006
First Posted (Estimate)
July 20, 2006
Study Record Updates
Last Update Posted (Actual)
June 28, 2017
Last Update Submitted That Met QC Criteria
April 11, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CA-09-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to share IPD.
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
LivaNovaRecruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
State Budgetary Healthcare Institution, National...RecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea-hypopnea | Obstructive Sleep Apnea-hypopnea SyndromeRussian Federation
-
ResMedCompletedObstructive Sleep Apnea (OSA)United States, Australia
-
The Hospital for Sick ChildrenCompleted
-
Cryosa, Inc.Active, not recruitingObstructive Sleep Apnea of AdultPanama, Paraguay
-
State Key Laboratory of Respiratory DiseaseCompletedObstructive Sleep Apnea of AdultChina
Clinical Trials on ApneaLink Sleep Screener
-
PMD SolutionsPortsmouth Hospitals NHS TrustCompleted
-
Sunnybrook Health Sciences CentreUnity Health TorontoCompletedStroke | Transient Ischemic Attack | Obstructive Sleep ApneaCanada
-
ResMedCompletedSleep Apnea Syndromes | Heart Failure, CongestiveAustralia
-
Columbia UniversityDelphi Devices BVCompleted
-
MetroHealth Medical CenterCompletedOSA | ACS - Acute Coronary Syndrome | Major Adverse Cardiac EventsUnited States
-
ResMedCompletedSleep Apnea, ObstructiveUnited States
-
University Health Network, TorontoSunnybrook Health Sciences Centre; Western UniversityRecruitingSleep Apnea | Neuropathic Pain | Spinal Cord Injuries | Spasticity, Muscle | Cardiovascular ComplicationCanada
-
Danish Headache CenterCompletedHeadache Disorders | Temporomandibular DisorderDenmark
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger Fund; Abell FoundationCompletedWomen's Health | Preconception CareUnited States
-
ResMedCompletedEvaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart FailureSleep Apnea Syndromes | Heart Failure, CongestiveAustralia